FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling FDA to weigh easing limits on unproven peptides promoted by RFK Jr. BPC 157: Experimental Peptide Creates Risk for Athletes The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York